検索結果 27 件
紙デジタル記事
国立国会図書館全国の図書館
- 要約等Cancer immunotherapy is designed to......e responses against tumor cells ......d is currently in use or under investigation for cancer treatments. Al...... reduce or eliminate tumor-induced immune su......n are either being developed or already in clinical trials. Th......iew deals with recent advances in cancer immunotherapy, focusing on new strate......of therapeutic cancer vaccines. Recently, several promising reports suggest that clinical benefit has been shown in randomized pha......trials for vaccines against prostate cancer, follicular ly......oma. Moreover, in 2010, the firs......tient-specific immunotherapy (sipuleucel-T) was approved b...
- 件名immunotherapy immune suppression cancer vaccine chemotherapy monoclonal anti...
- 参照... Controlled by Inducible Nitric ......moimmunomodulating Property of D......ppressor Cells in Tumor Bearers ......ugh TLR4 signaling in mice A randomi......taxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer. Combination of Docetaxel and Recombinant Vaccine Enhances T-Ce......rameters affecting the efficacy ......se I Study of Single-Agent Anti–......h-1 (MDX-1106) in Refractory Sol......ors: Safety, Clinical Activity, ......elates Gemcitabine Selectively Eliminates Splenic Gr......ppressor Cells in Tumor-Bearing Animals and E......n Sipuleucel-T Immunotherapy for Castration-Resistant Pros...
デジタル記事
インターネットで読める全国の図書館
- 要約等...ystem to fight cancer is not a novel concept; in 1891, Coley re...... of sarcoma by inoculation with erysipelas [......
- 参照... Lung Adenocarcinomas The Resist......isms of Checkpoint Inhibitors in Solid Tumors T......ssibilities of Immunotherapy for Children w......ssociated with Cancers Epigenetic Me...... Immune Checkpoint Inhibitors Vitamin D Prevents Pancreatic Cancer-Induced Apoptosis Signaling of Inflammatory Cell...... immune-checkpoint inhibitors in cancer therapy Clinical and pathol......atures of lung cancer expressing programmed ce......mmunotherapies in Melanoma and Non-Melanoma Skin Cancers
紙図書
国立国会図書館
紙図書
国立国会図書館
- 内容細目The impact of vaccination on the epidemiology of infectious diseases How vaccines work Vaccine design in the 21st Century Vaccine adjuvants Vaccine production: main steps and cons......ns How are vaccines assessed in clinical trials? Im......relates of vaccine-mediated protection How vaccine safety is monitored Vaccination and autoi......zation: protecting vulnerable po...... pertussis vaccines Pneumococcus......llomavirus vaccines Rotavirus vaccines Antiviral vaccines: challenges and advances New approaches......for needed vaccines: bacteria Vaccines against parasites Tuberculosis vaccines Major global vaccine challenges: recent progress ...
- 件名Vaccines. Vaccines--immunology. Drug Design. I...
紙図書
国立国会図書館全国の図書館
- 内容細目... for tissue engineering Recent advances in 3D tissue mode...... aggregation using micro-nano te...... Arai 著 Rapid single cell printing by piezoelectric inkjet printer Ryanto The ほか著 Engineering electrospun s......encourage cell infiltration H. S......ru Akashi 著 Engineering cellular asse......r applications in regenerative medicine Christopher M......stem cells and induced pluripote......ulture systems in vitro Maiko Hi......elastic fibers in three-dimensio......shikawa 著 Building experimental system modeling fibrotic tissue in human pancreatic cancer by three-dimen......ano 著 Human living skin equivalents as a promising mo...
- 関連情報Nanomedicine and nanotoxicology
- 掲載誌Nanomedicine and nanotoxicology
紙デジタル記事
国立国会図書館全国の図書館
- DOI10.11406/rinketsu.57.2388
- 件名Cancer immunotherapy Chimeric antig...... Immune checkpoint inhibitors Neoantigen
- 並列タイトル等（連結）Recent advances and future challenges in cancer immunotherapy
紙図書
国立国会図書館
- 目次・記事RECENT ADVANCES OF HUMAN TUMOR......IMMUNOLOGY AND IMMUNOTHERAPY CONTENTS Prefa...... to Autologous Cancer : Rationale of Immunotherapy of Human Cancer with CTL/ 3 K. KIKUCHI||N. SATO CHARACTE......GENS T-cell Defined Tumor Antige......rspectives for Cancer Vaccine Development/ ......astric Signet Ring Cell Carcinomas/ 31 N. SATO||Y. OKADA||K. SUZUKI||H. SAHARA||T. YASOSHIMA||Y. HIROHASHI||Y. NABETA||I. HIRAI||T. TORIGOE||S. TAKAHASHI||N. TAKAHASHI||A. SASAKI||M. SUZUKI||J. HAMURO||H. IKEDA||Y. WADA||K. HIRATA||K. KIKUCHI A Gene Encoding Squamous Cell Carcinoma Antigens Re...... 43 S. SHICHIJO||M. NAKAO||Y. IMAI||H. TAKASU||...
- 内容細目...nity by R. Offringa et al MUC1 a......mor antigens using the antibody repertoire of cancer patients by O.......r et al Killer inhibitory receptor in human T cells ...... apoptosis and cancer by J. Tschopp,......e responses by introduction of B7 genes into tumors by N.......ses The triggering and healing of tumor stromal inflammatory reac......hanisms underlying T cell migrat......ible for IL-12-induced tumor reg......ionale for vaccine construction and clinical trials Ide......nized by tumor infiltrating T lymphocytes...... their use for immunotherapy by Y. Kawakami Challenges in the specific immunotherapy of cancer by E. Jager, D. Jag...
- シリーズ著者・編者[by] Japanese Cancer Association
デジタル記事
インターネットで読める全国の図書館
- 要約等Cancer immunotherapy is designed to......e responses against tumor cells ......d is currently in use or under investigation for cancer treatments. Al...... reduce or eliminate tumor-induced immune su......n are either being developed or already in clinical trials. Th......iew deals with recent advances in cancer immunotherapy, focusing on new strate......of therapeutic cancer vaccines. Recently, several promising reports suggest that clinical benefit has been shown in randomized pha......trials for vaccines against prostate cancer, follicular ly......oma. Moreover, in 2010, the firs......tient-specific immunotherapy (sipuleucel-T) was approved b...
- 件名monoclonal antibodies chemotherapy cancer vaccine immune suppression immunotherapy
- 並列タイトル等（連結）Recent Advances in Cancer Immunotherapy
紙図書
全国の図書館
- 一般注記...Haruo Sugiyama Include bibliographical referenc...
- 関連情報Princess Takamatsu symposia
- 掲載誌Princess Takamatsu symposia
デジタル記事
インターネットで読める全国の図書館
- 要約等<jats:p> Our increasing understanding of the molecu......acteristics of cancer and of cancer genomics is facilitating the development of immunotherapy and molecular ......gs for gastric cancer. After the app...... immune checkpoint inhibitors (ICIs) for melanoma in 2010, many different cancers have been sho......olong survival in 2017, and ICIs......e become the mainstay of treatme......opment. Many clinical trials of combination therapies......as well as combinations of immun......utic agents acting via different......ach treatment line. As a result,......r improvements in therapeutic ou......es for gastric cancer are anticipated in the near f...
- 参照...ageal junction cancer (KEYNOTE-061):......microsatellite instability status in various unrese......Plus Nivolumab in Patients With ...... or Colorectal Cancer: An Open-Label......, EPOC1603) A single dose of neo......ade predicts clinical outcomes in resectable mel......r immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associat...... pembrolizumab in patients with ......ageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase ......al EANO–ESMO Clinical Practice Guidelines for diagnosi......tients with brain metastasis fro......T chemotherapy in resectable gas......ageal junction cancer Pembrolizumab versus paclitax...
デジタル記事
全国の図書館
- 件名Drug Discovery Pharmacology Molecular Medicine Immunology
- 参照Clinical implicatio......cp> expression in breast cancer
- 出版者（掲載誌）Informa UK Limited
デジタル記事
全国の図書館
- 参照cGAS-STING signaling encourages im......ne cell overcoming of fibroblast barricades in pancreatic cancer
- 出版者（掲載誌）OAE Publishing Inc.
デジタル記事
全国の図書館
- 件名General Medicine General Chemistry
- 参照DNA‐Based Nanoarchitectures as Eminent Vehicles for Smart Drug De...
- 著者標目Ling Li Zhen Yang Xiaoyuan Chen
デジタル記事
全国の図書館
- 要約等...:title><jats:p>Immunotherapy will significa......andard of care in cancer treatment. Recent advances in nanotechnology......he efficacy of cancer immunotherapy. However, concerns regarding efficiency of cancer nanomedicine, complex tumo......toxicity drive interest in more novel app......eloped to make innovative changes in the delivery a...... advance the clinical efficacy of cancer immunotherapy. Thus there is......ogy for developing effective cancer immunotherapeu......at demonstrate increased specifi......d potency. The recent works and stat......technology for cancer immunotherapy.</jats:p>
- 件名Pharmaceutical Science Biomedical Engineering Biomaterials
- 著者標目Faisal Raza Hajra Zafar Shulei Zhang Zul Kamal Jing Su Wei‐En Yuan Qiu Mingfeng
デジタル記事
全国の図書館
- 要約等... immune checkpoint inhibitors for th......mall cell lung cancer has inspired many clinical trials to ...... immune checkpoint inhibitors in earlier stages of lung cancer worldwide. Bas......ue are present in vivo, some clinical trials have recently evaluated th...... immune checkpoint inhibitors. Some ...... immune checkpoint inhibitors in a neoadjuvant setting, with a favor......dverse events. In the most impac......from Johns Hopkins University an......al Sloan Kettering Cancer Center, the pr......gramed death-1 inhibitor nivolumab was administered to 21 patients in a neoadjuvant setting. The authors ......neoadjuvant administration of immune checkpoint...
- 件名Cancer Research Radiology, Nuclear Medicine and imaging Oncology General Medicine
- 参照18F-FDG PET/CT in non-small-cell lung cancer patients Cancer immunotherapy using checkpoint blockade Peri......adverse events in advanced non-small cell lung cancer treated with PD-1 inhibitors Report......udoprogression in patients with ......mall cell lung cancer treated with nivolumab—including histological ......rent Status of Immunotherapy for Lung Cancer and Future Per......on of Survival in Patients with ......mall-Cell Lung Cancer after Neoadjuv......mall cell lung cancer (NSCLC) PD-1 and PD-L1 Protein Expression Predict Survival in Completely Res...... Lung Adenocarcinoma Neoadjuvant......d chemotherapy in patients with resectable non-...
デジタル記事
全国の図書館
- 要約等<jats:p>Cancer stem cells (CS......the relapse of cancer cells and meta...... resistance against most chemoth......ity and cause minimal residual disease. In order to achie......o be targeted. Recent advances in immunotherapie......ve shown promising outcomes in curing cancer, which are als......haracteristics in various cancers, which can be used in immunotherapie......to target CSCs in the tumor microenvironment. Recently, various str......(DC)-based vaccines, oncolytic v...... immune checkpoint inhibitors, and combination therapies are now being used to targe......oaches and the recent trends in immunotherapies to target CSC...
- DOI10.3390/cancers11030310
- 件名Cancer Research Oncology
デジタル記事
全国の図書館
- 件名General Medicine
- 参照...cell responses in breast cancer An IL‐12‐Based Nanocytokine Safely Potentiates Anticancer Immunity throu......ral Control of Inflammation to Eradicate Advanc...
- 出版者（掲載誌）Springer Science and Business Media LLC
デジタル記事
全国の図書館
- 要約等...ynergistic combination cancer immunotherapy strategies based on nanomater...
- 参照Tumor-dilated polymersome nanofactories for enhanced enzyme prodrug chemo-immunotherapy
デジタル記事
全国の図書館
- 件名Pharmacology General Medicine
- 参照Hepatocellular carcinoma progression......enase activity in CD163(+) tumor-associated mac...
- 著者標目...a Khosravi Afshin Derakhshani Ha......r Alemohammad Mina Afrashteh Nour Hossein Safarpour Nicola Silvestris O...
デジタル記事
全国の図書館
- 参照SPC18 Expression Is an Independent Prognostic Indicator of Pati......amous Cell Carcinoma
- 著者標目Marine Leclerc Laura...... Isabelle Tihy Ines Malenica Salem Chouaib Fath...